## Flibanserin 100mg (50 Tablets)

**Flibanserin 100mg** is a selective serotonin receptor modulator that has attracted considerable attention in scientific and medical research communities. Also known by its brand name Addyi in pharmaceutical contexts, **Flibanserin 100mg** serves as a valuable tool for researchers investigating neurotransmitter systems, sexual motivation pathways, and hypoactive sexual desire disorder (HSDD) mechanisms. Each bottle of this research compound contains **50 tablets** of **100mg Flibanserin**, delivering a total of 5,000mg for comprehensive laboratory protocols.

Developed initially as a potential antidepressant before its repurposing for sexual health studies, **Flibanserin 100mg** functions primarily as a 5-HT1A receptor agonist and a 5-HT2A receptor antagonist. This dual action influences key brain chemicals, increasing levels of dopamine and norepinephrine while reducing serotonin activity in specific regions, particularly the prefrontal cortex. Such modulation makes it an important subject in neuroscience and endocrinology research focused on desire, arousal, and mood regulation.

The pharmacological profile of **Flibanserin 100mg** is both unique and complex. Unlike hormonal treatments, it acts centrally within the nervous system rather than on peripheral organs. By agonizing 5-HT1A receptors and antagonizing 5-HT2A receptors, **Flibanserin 100mg** helps rebalance neural circuitry involved in processing sexual cues and motivation.

Researchers note additional moderate antagonistic effects on 5-HT2B, 5-HT2C, and dopamine D4 receptors. This multifaceted interaction profile allows scientists to explore how subtle shifts in serotonin, dopamine, and norepinephrine signaling can influence complex behavioral outcomes. Pharmacokinetic studies indicate that **Flibanserin 100mg** reaches peak plasma concentration in approximately 0.75 hours after oral administration, with an absolute bioavailability of around 33%. Metabolism occurs primarily via CYP3A4 and CYP2C19 enzymes, which is critical information for interaction studies in laboratory models.

In preclinical and clinical research settings, these properties have enabled detailed investigations into how neurotransmitter imbalances contribute to diminished sexual interest, providing insights that extend beyond HSDD into broader fields of psychopharmacology and behavioral neuroscience.

### Key Research Applications of Flibanserin 100mg

**Flibanserin 100mg** is predominantly utilized in studies related to:

– **Hypoactive Sexual Desire Disorder (HSDD)**: As the first non-hormonal compound approved for this condition in certain pharmaceutical forms, it remains a benchmark for research into acquired, generalized low sexual desire in women.

– **Neurotransmitter Modulation**: Examining the interplay between serotonin, dopamine, and norepinephrine in motivation and reward pathways.

– **Female Sexual Function**: Investigating desire, arousal, satisfaction, and distress metrics in controlled experimental designs.

– **Mood and Cognitive Research**: Exploring secondary effects on mood regulation and prefrontal cortex activity.

Additional emerging areas include studies on postmenopausal populations and potential applications in related sexual health models, although all such work must remain strictly within ethical laboratory boundaries.

### Potential Outcomes Observed in Research Studies

Multiple randomized, double-blind, placebo-controlled trials have provided data on **Flibanserin 100mg**. In key Phase 3 studies (such as VIOLET, DAISY, and BEGONIA), researchers observed modest increases in the number of satisfying sexual events (SSEs), improvements in desire scores measured by tools like the Female Sexual Function Index (FSFI) desire domain, and reductions in sexual distress as assessed by the Female Sexual Distress Scale.

Pooled analyses across thousands of participants typically report an average increase of approximately 0.5 additional SSE per month compared to placebo, alongside measurable but modest gains in desire metrics. These findings have fueled ongoing discussions in the scientific community regarding the compound’s efficacy profile and the importance of individualized response variability in research models.

Postmenopausal research, including the SNOWDROP trial, has similarly explored efficacy and safety parameters, expanding the potential scope of investigations using **Flibanserin 100mg** in laboratory settings.

It is essential to emphasize that these results stem from highly controlled clinical research environments and do not translate directly to real-world or non-research applications.

### Product Specifications – Flibanserin 100mg Research Chemical

– **Active Compound**: Flibanserin (high-purity research grade)

– **Dosage per Tablet**: 100mg

– **Tablet Count**: 50 tablets per bottle

– **Total Content**: 5,000mg

– **Form**: Compressed tablets designed for accurate laboratory dosing

– **Purity**: Laboratory-grade, suitable for analytical and experimental use

– **Storage Conditions**: Cool, dry place protected from light and moisture

– **Shelf Life**: Stable for extended periods when stored correctly

– **Intended Use**: Exclusively for laboratory research, in-vitro studies, and analytical purposes

This tablet formulation offers researchers convenience and precision compared to powder forms, minimizing handling errors in experimental setups.

Suggested Research Protocols and Dosing Considerations (Laboratory Use Only)

In published research protocols, FLIBANSERIN (100MG) (50 TABLETS) is commonly administered as a single daily dose, often timed for evening to align with observed sedative properties. Exact parameters vary significantly depending on the specific study objectives, animal models, cell lines, or in-vitro systems being employed. Researchers must consult primary literature and institutional review boards for appropriate experimental design.

Factors such as CYP enzyme activity, potential drug interactions (particularly with CYP3A4 modulators), and subject characteristics are critical variables in any rigorous study involving this compound.

Comprehensive Safety Profile and Important Research Considerations

While FLIBANSERIN (100MG) (50 TABLETS) has been evaluated extensively in controlled settings, its safety profile includes notable adverse events. Common observations in studies include dizziness, somnolence, nausea, fatigue, insomnia, and dry mouth. There is also an increased risk of hypotension and syncope, particularly when combined with alcohol or certain other substances in experimental models.

Discontinuation rates due to adverse events tend to be higher than placebo, underscoring the need for careful monitoring in any research context. Long-term data and interaction studies continue to be areas of active scientific interest.

**Critical Disclaimer**: This product, FLIBANSERIN (100MG) (50 TABLETS), is sold strictly for laboratory and scientific research purposes only. It is **not for human consumption**, therapeutic use, diagnostic purposes, or any form of self-experimentation. The compound carries significant risks and should never be used outside of approved research facilities following all ethical and legal guidelines. Researchers must comply with all applicable local, national, and institutional regulations.

 Broader Scientific Context and Future Research Directions

The development history of **Flibanserin 100mg**—from initial antidepressant candidate to HSDD research tool—highlights the serendipitous nature of pharmacological discovery. Its approval pathway involved multiple advisory committees, extensive safety evaluations, and ongoing post-marketing surveillance, providing rich material for meta-research and pharmacovigilance studies.

Current and future research may delve deeper into genetic factors (such as CYP2C19 polymorphisms) affecting response, combination approaches with other modalities, neuroimaging correlates of its effects, and potential applications in related conditions. The compound continues to serve as a valuable probe for understanding the neurobiology of desire and motivation.

 Why Choose This FLIBANSERIN (100MG) (50 TABLETS) Formulation for Your Research?

– Precise 100mg dosing per tablet for reproducibility

– Convenient tablet form suitable for various experimental designs

– Generous 50-tablet supply supporting multi-week or multi-subject protocols

– High-purity research grade material

– Clear labeling and professional packaging for laboratory environments

 Frequently Asked Questions About FLIBANSERIN (100MG) (50 TABLETS)

**Q1: What is Flibanserin 100mg?**

**A:** Flibanserin 100mg is a serotonin receptor modulator (primarily 5-HT1A agonist and 5-HT2A antagonist) used in laboratory research on neurotransmitter balance, HSDD mechanisms, and sexual motivation pathways. Each bottle contains 50 tablets of 100mg.

**Q2: What does Flibanserin 100mg research focus on?**

**A:** Researchers study **Flibanserin 100mg** for its effects on dopamine and norepinephrine enhancement, serotonin modulation, sexual desire metrics, and related neurochemical processes in controlled experimental settings.

**Q3: How many tablets are in one bottle of Flibanserin 100mg?**

**A:** One bottle contains **50 tablets** of **100mg Flibanserin** each, providing a total of 5,000mg for research use.

**Q4: Is Flibanserin 100mg legal for research?**

**A:** It is legal to purchase and use for legitimate laboratory research in many jurisdictions. However, it is a regulated compound with specific therapeutic approvals under the name Addyi. This product is strictly for research purposes. Always verify local regulations.

**Q5: What is the typical research dosage for Flibanserin 100mg?**

**A:** Published protocols often reference 100mg daily (frequently at bedtime in human studies), but exact usage depends entirely on the research design and must follow scientific literature and ethical guidelines.

**Q6: Is Flibanserin 100mg safe for human use?**

**A:** **No** – this research chemical is **not for human consumption**. It carries risks including dizziness, somnolence, nausea, hypotension, and syncope. Use is restricted to controlled laboratory environments only.

**Q7: How should I store Flibanserin 100mg tablets?**

**A:** Store in a cool, dry place away from direct light and moisture to preserve the integrity of the research compound.

**Q8: What is the difference between Flibanserin and Addyi?**

**A:** Flibanserin is the active pharmaceutical ingredient; Addyi is the FDA-approved brand name product for specific therapeutic indications. The research version is for laboratory study only.

**Q9: Can Flibanserin 100mg be used for performance enhancement?**

**A:** Absolutely not. This compound is intended **strictly for laboratory research**. It is not approved or safe for any non-research human applications.

**Q10: What is the purity level of your Flibanserin 100mg?**

**A:** Our product is high-purity research grade, appropriate for analytical chemistry and experimental research applications.